Similar articles

• [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].

  Shimoyama S, Kondo K, Kataoka M. Shimoyama S, et al. Nihon Rinsho. 2003 Sep;61 Suppl 7:356-9. Nihon Rinsho. 2003. PMID: 14574912 Review. Japanese. No abstract available.
• Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.

  Fisher MD. Fisher MD. Clin Colorectal Cancer. 2001 Aug;1(2):85-6. doi: 10.1016/S1533-0028(11)70542-4. Clin Colorectal Cancer. 2001. PMID: 12445365 Review. No abstract available.
• Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.

  Liu JH. Liu JH. Clin Colorectal Cancer. 2004 Sep;4(3):204-5. doi: 10.1016/s1533-0028(11)70118-9. Clin Colorectal Cancer. 2004. PMID: 15377404 No abstract available.
• Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?

  Punt CJ. Punt CJ. Ann Oncol. 2005 Jun;16(6):845-6. doi: 10.1093/annonc/mdi196. Epub 2005 May 12. Ann Oncol. 2005. PMID: 15890668 No abstract available.
• Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.

  Yao Y, Sun YJ, Zhao H, Guo YW, Lin F, Cai X, Tang XC, Tang LN, Zhang W. Yao Y, et al. Chin Med J (Engl). 2006 Nov 5;119(21):1829-33. Chin Med J (Engl). 2006. PMID: 17097039 No abstract available.